Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The clinical trial...
-
Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Patient Recruitment Services Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Clinical...
-
Dublin, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The "Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.Report...
-
Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added...
-
Dublin, July 16, 2025 (GLOBE NEWSWIRE) -- The "CD123 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025" report has been added to ...
-
Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030" report has been added to ...
-
Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report" report has been added to ...
-
Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Global PROTAC Targeted Protein Degraders Market Opportunity & Clinical Trials Insight 2027" report has been added to ResearchAndMarkets.com's...
-
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's offering. CD70...
-
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering. ...